Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 53,109 | 50,397 | 62,621 | 47,915 | 32,075 |
| Income taxes - deferred | -3,243 | -9,126 | -17,125 | -7,636 | -2,012 |
| Accounts receivable | -10,288 | 5,575 | -29,958 | 8,577 | 18,365 |
| Accounts payable and accrued liabilities | 632 | -21,629 | 30,601 | 11,455 | -46,856 |
| Other Working Capital | -19,624 | -28,013 | -9,989 | 627 | -21,607 |
| Other Operating Activity | 15,694 | 38,735 | 4,331 | -16,320 | 7,830 |
| Operating Cash Flow | $36,280 | $35,939 | $40,481 | $44,618 | $-12,205 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,369 | 974 | -2,885 | -3,832 | -5,378 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -170,855 |
| Purchase Of Investment | -162,570 | -334,163 | -185,473 | -64,321 | -53,941 |
| Sale Of Investment | 210,808 | 347,901 | 150,544 | 180,541 | 269,378 |
| Purchase Sale Intangibles | -29,003 | -9,008 | -22,931 | -220,351 | -15,290 |
| Other Investing Activity | 97 | 23,637 | -2,334 | 2,684 | 77,439 |
| Investing Cash Flow | $16,963 | $29,341 | $-63,079 | $-105,279 | $101,353 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,473 | 4,796 | 51,783 | 9,423 | 24,581 |
| Debt Repayment | -21,524 | -22,820 | -20,292 | -23,615 | -17,853 |
| Common Stock Repurchased | -8,866 | -53,479 | -30,069 | -64,415 | -36,787 |
| Other Financing Activity | -6,623 | -9,499 | 340 | 297 | 826 |
| Financing Cash Flow | $-33,540 | $-81,002 | $1,762 | $-78,310 | $-29,233 |
| Exchange Rate Effect | 1,642 | 2,804 | 6,552 | -4,658 | -4,592 |
| Beginning Cash Position | 58,761 | 71,679 | 85,963 | 229,592 | 174,268 |
| End Cash Position | 80,106 | 58,761 | 71,679 | 85,963 | 229,592 |
| Net Cash Flow | $19,703 | $-15,722 | $-20,836 | $-138,971 | $59,916 |
| Free Cash Flow | |||||
| Operating Cash Flow | 36,280 | 35,939 | 40,481 | 44,618 | -12,205 |
| Capital Expenditure | -31,472 | -9,958 | -25,816 | -224,183 | -20,668 |
| Free Cash Flow | 4,808 | 25,981 | 14,665 | -179,565 | -32,873 |